136888-26-1

Basic information

• Product Name: 5,6-dichloro-1H-pyrrolo[3,2-b]pyridin-2(3H)-one
• Synonyms: 5,6-dichloro-1H-pyrrolo[3,2-b]pyridin-2(3H)-one;5,6-dichloro-1,3-dihydro-2H-pyrrolo[3,2-b]pyridin-2-one
• CAS NO: 136888-26-1
• Molecular Formula: C7H4Cl2N2O
• Molecular Weight: 203.028
• Mol File: 136888-26-1.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 372.564°C at 760 mmHg
• Flash Point: 179.121°C
• Appearance: /
• Density: 1.584g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.623
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 5,6-dichloro-1H-pyrrolo[3,2-b]pyridin-2(3H)-one(CAS DataBase Reference)
• NIST Chemistry Reference: 5,6-dichloro-1H-pyrrolo[3,2-b]pyridin-2(3H)-one(136888-26-1)
• EPA Substance Registry System: 5,6-dichloro-1H-pyrrolo[3,2-b]pyridin-2(3H)-one(136888-26-1)

Safety Data

• Hazardous Substances Data: 136888-26-1(Hazardous Substances Data)

Usage

General Description

5,6-dichloro-1H-pyrrolo[3,2-b]pyridin-2(3H)-one is a chemical compound with the molecular formula C7H3Cl2N2O. It is a heterocyclic compound that consists of a pyrrolopyridine ring fused to a pyrazin-2(3H)-one. 5,6-dichloro-1H-pyrrolo[3,2-b]pyridin-2(3H)-one is a chlorinated derivative of the parent compound, pyrrolo[3,2-b]pyridin-2(3H)-one. It has potential applications in pharmaceuticals and agrochemicals due to its unique structure and properties. 5,6-dichloro-1H-pyrrolo[3,2-b]pyridin-2(3H)-one is of interest to researchers and industry professionals for its potential as a starting material for the synthesis of novel bioactive molecules. Its precise applications and properties are still being studied and explored.

InChI:InChI=1/C7H4Cl2N2O/c8-3-1-4-5(11-7(3)9)2-6(12)10-4/h1H,2H2,(H,10,12)

Upstream product

• 21427-62-3 2,5-dichloro-3-nitropyridine 
• 55304-72-8 2,5,6-trichloro-3-nitropyridine 
• 105-53-3 diethyl malonate 

Relevant articles and documents

AZAINDOLE DERIVATIVE HAVING AMPK-ACTIVATING EFFECT

Disclosed is a compound which is useful as an AMPK activator. A compound represented by formula: or its pharmaceutically acceptable salt, wherein X is substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted cycloalkenyl, or substituted or unsubstituted heterocyclyl; R1 is hydrogen, halogen, cyano, nitro, carboxy, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted acyl, substituted or unsubstituted carbamoyl, substituted or unsubstituted alkylthio, substituted or unsubstituted alkylsulfinyl, substituted or unsubstituted alkylsulfonyl, or substituted or unsubstituted alkyloxycarbonyl; R2 is halogen, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted cycloalkenyl, substituted or unsubstituted heterocyclyl, or the like; R3 is halogen, hydroxy, cyano, nitro, carboxy, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted cycloalkenyl, substituted or unsubstituted heterocyclyl, or the like; and R4 is hydrogen, halogen, hydroxy, cyano, nitro, carboxy, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, or the like.

Synthesis of substituted azaoxindoles for the preparation of aza-tenidap analogs

The preparation of a set of eight azaoxindoles bearing substituents on the aromatic nucleus is outlined. These compounds were required for the preparation of aza-analogs of the anti-inflammatory oxindole tenidap. Two methods of synthesis were used, the fi